AI in Science and Research

Protein structure prediction is the computation of a protein's three-dimensional structure from its amino-acid sequence. AlphaFold is a family of deep-learning systems from Google DeepMind (with later work at Isomorphic Labs) that, since its second version in 2020, predicts single-protein structures with accuracy that a community blind test assessed as rivalling experimental structures in most cases, and whose later version extends to complexes with nucleic acids, small molecules and ions.

Experimental determination of a structure (X-ray crystallography, cryo-electron microscopy, NMR) takes months to years of effort per protein (Jumper et al., 2021). Sequences are known for far more proteins than have experimental structures. A fast, accurate predictor therefore changes which structural questions can be asked. This article is the detailed case study of the most thoroughly validated AI-for-science result; the broader field is covered in APP-SCI-001, which is not repeated here. Evidence is sorted into three classes:

The prediction of structure from sequence was framed as a "grand challenge" for about half a century after Anfinsen's work on sequence-structure relations. Progress was tracked by CASP (Critical Assessment of protein Structure Prediction), a biennial community experiment with blind testing and independent assessment, first run in 1994 (Baek et al., 2021, for context; Kryshtafovych et al., 2021). In CASP14 (2020), the assessors reported that deep-learning methods from one group consistently delivered computed structures rivaling experimental ones in accuracy, a result they described as a solution to the classical protein-folding problem at least for single proteins (Kryshtafovych et al., 2021). The method was published in 2021 (Jumper et al., 2021). The same year, a second group published RoseTTAFold, a three-track network that approached AlphaFold's accuracy (Baek et al., 2021), and DeepMind with EMBL-EBI released predictions for almost the entire human proteome (Tunyasuvunakool et al., 2021) and opened the AlphaFold Protein Structure Database (Varadi et al., 2022). A protein language model approach, ESM-2, followed in 2023 (Lin et al., 2023). AlphaFold 3 was described in 2024 (Abramson et al., 2024). In 2024 the Nobel Prize in Chemistry was awarded half to David Baker for computational protein design and half to Demis Hassabis and John Jumper for protein structure prediction (Nobel Prize Outreach, 2024; reported by news sources, citation to the Nobel announcement page to be confirmed).

Inputs and representation. AlphaFold 2 takes the target sequence, a multiple sequence alignment (MSA) of related sequences and optionally template structures. Jumper et al. describe a redesigned neural network that incorporates physical and biological knowledge about protein structure, using multi-sequence alignments, in the design of the deep-learning algorithm (Jumper et al., 2021).

Outputs and confidence. The system returns atomic coordinates together with per-residue and pairwise confidence estimates and predicted aligned errors (Varadi et al., 2022). Per-residue confidence is reported on a 0-100 scale (pLDDT). The confidence outputs are part of the model, not an afterthought, and are needed to interpret results: low-confidence regions are often disordered.

Accuracy metrics. CASP compares a predicted structure with the experimental one after superposition, using measures such as the global distance test, the fraction of residues within given distance cut-offs of their true positions. Because the experimental structure can itself be uncertain, assessment includes comparison with experimental density.

AlphaFold 3. The third version uses a substantially updated diffusion-based architecture to predict the joint structure of complexes of proteins, nucleic acids, small molecules, ions and modified residues (Abramson et al., 2024). The paper reports far greater accuracy for protein-ligand interactions than state-of-the-art docking tools, much higher accuracy for protein-nucleic acid interactions than nucleic-acid-specific predictors, and substantially higher antibody-antigen accuracy than AlphaFold-Multimer v2.3. For diffusion models see TECH-DIFF-001.

Language-model approach. ESM-2 scaled protein language models up to 15 billion parameters and inferred atomic-level structure directly from a single sequence, giving an order-of-magnitude speed-up and enabling structure prediction for more than 617 million metagenomic sequences, over 225 million of them with high confidence (Lin et al., 2023). Accuracy relative to MSA-based AlphaFold depends on the protein class and was not compared here.

• Single-chain structure prediction: AlphaFold 2, RoseTTAFold, ESM-2 (and related folding models).
• Complex prediction: protein-protein (AlphaFold-Multimer), and protein with nucleic acids, ligands and ions (AlphaFold 3).
• Databases: AlphaFold Protein Structure Database (predictions), distinct from the experimental Protein Data Bank.
• Downstream design tools: inverse folding (ProteinMPNN) and generative backbone design (RFdiffusion) that use structure-prediction ideas to design new proteins (Dauparas et al., 2022; Watson et al., 2023).

#6.1 Deployed resources

• AlphaFold Protein Structure Database. Created by Google DeepMind and EMBL-EBI. The initial release in 2021 contained over 360,000 predicted structures across 21 model-organism proteomes (Varadi et al., 2022). As of the database's website in 2026, it states open access to over 200 million predictions under a CC-BY-4.0 licence (EMBL-EBI, 2026; value read through a search summary, [VERIFICATION NEEDED: confirm on the site and note date]). Current counts belong in the Living Reference collections.
• Human proteome. Predictions for 98.5% of human proteins covered 58% of residues with a confident prediction, 36% of all residues at very high confidence, compared with 17% of residues covered by experimental structures at the time (Tunyasuvunakool et al., 2021).

#6.2 Validated results

• CASP14 blind test. Independent assessors reported that the deep-learning predictions from one group rivalled experimental structures in accuracy, and that the models were already helpful for problematic crystal structures (Kryshtafovych et al., 2021). The AlphaFold paper reports accuracy competitive with experimental structures in a majority of cases and greatly outperforming other methods (Jumper et al., 2021).
• Comparison with crystallographic maps. Terwilliger et al. (2024) compared predictions directly with experimental electron-density maps. In many cases predictions matched closely; in others even very high-confidence predictions differed on a global scale (distortion, domain orientation) and locally (backbone and side-chain conformations). The authors recommend treating predictions as "exceptionally useful hypotheses" and verifying details experimentally, especially interactions that were not part of the prediction.

#6.3 Research demonstrations

• AlphaFold 3 complexes (Abramson et al., 2024). Evidence is the developers' benchmark comparisons; at the time of drafting, broad independent evaluation of each claim was not verified [VERIFICATION NEEDED: independent benchmarks of AlphaFold 3; and the terms under which model weights are available].
• Generative design. ProteinMPNN reported sequence recovery of 52.4% on native backbones versus 32.9% for Rosetta, with experimental validation of previously failed designs (Dauparas et al., 2022). RFdiffusion applied diffusion to de novo protein design (Watson et al., 2023). These are design methods (see APP-SCI-001), not structure predictors.

Advantages. Speed (a prediction replaces months of experiment as a first model), open databases, and confidence estimates that flag unreliable regions.

Limitations.

• Predictions are models. High-confidence predictions can still deviate from experiment in domain arrangement and local conformation, and the method does not account for ligands, covalent modifications or environmental factors in its single-chain form (Terwilliger et al., 2024).
• Single static structures. The headline problem solved at CASP14 was prediction of single-protein structures (Kryshtafovych et al., 2021); the dynamic ensembles that determine function are a separate scientific question.
• Disorder and low-confidence regions. Confidence outputs flag regions that are likely disordered (Tunyasuvunakool et al., 2021).
• From structure to drug. A predicted structure does not by itself yield a drug. No source verified in this draft shows an approved medicine whose discovery depended on AlphaFold predictions; the claim that AlphaFold accelerates drug discovery is Preliminary and should be read against the long timescale of drug development (see APP-HEALTH-001 for clinical evidence standards).
• Dual use. Better structure prediction and design tools may lower barriers to harmful biological design; this is discussed in SAFE-XRISK-001 and is not evidenced by the sources used here.

Unresolved questions. Accuracy for novel folds, multi-chain assemblies, conformational change and effects of mutations; how to benchmark complex prediction independently; how structure-prediction tools combine with experimental pipelines.

As of 2026-10-15: single-protein structure prediction at near-experimental accuracy for most targets is Established as a CASP-validated result and by independent comparison with experimental maps, with documented exceptions (Well Supported to Established, depending on the claim). The practice of treating predictions as hypotheses to verify is the recommendation of crystallographers who tested them (Terwilliger et al., 2024). AlphaFold 3's complex-prediction advantages are Preliminary pending independent evaluation. The 2024 Nobel Prize recognised both structure prediction and computational protein design.

Near-term (0-3 years): broader complex and ensemble prediction, integration with experimental data, larger databases of predicted complexes (EMBL-EBI has announced plans in 2026 to add millions of predicted complexes, per search summary; unverified). Medium-term (3-10 years): routine use in drug and enzyme discovery pipelines; structure-aware generative design. Long-term claims, such as a general ability to design arbitrary functional proteins, are speculative.

• Foundational Concepts:
  • APP-SCI-001 AI in Scientific Discovery: The broader field in which this case study sits.
  • TECH-DL-001 Deep Learning: Training methods.
• Related Methods & Technologies:
  • TECH-DIFF-001 Diffusion Models: Architecture used in AlphaFold 3 and RFdiffusion.
  • TECH-LLM-001 Large Language Models: Background for protein language models.
  • APP-HEALTH-001 AI in Healthcare and Medicine: Clinical evidence standards for downstream use.
• Advanced Implications & Future Trajectories:
  • SAFE-XRISK-001 Existential Risk from AI: Biological misuse discussion.

AI in Scientific Discovery (AI4Science) refers to the application of artificial intelligence—specifically deep learning, generative models, and autonomous agents—to accelerate, automate, or fundamentally augment the scientific method. This encompasses the parsing of massive multi-dimensional scientific datasets, the prediction of complex physical and biological structures (such as protein folding and molecular docking), the proposal of candidate materials, and efforts to build automated or "self-driving" laboratories that combine experiment planning with robotic execution. Protein structure prediction is exemplified by Jumper et al. (2021); that paper does not address automated laboratories, and no source for self-driving labs is cited here [VERIFICATION NEEDED: cite a peer-reviewed review of self-driving laboratories].

The integration of AI into the natural sciences is described by proponents as a shift toward computation-guided discovery, in which models identify patterns in high-dimensional data. Experimental validation remains central, and the extent of the change varies by field.

Reported or claimed benefits include the following; speed-ups vary widely by problem:

1. Accelerating R&D Cycles: Developers and commentators claim that AI can shorten parts of drug-candidate and materials discovery; no specific case, metric or source is cited here [VERIFICATION NEEDED: cite measured examples].
2. Solving Intractable Physics: Neural network surrogates have been reported to approximate solutions of physical simulations much faster than numerical solvers in specific cases; the speed-up depends on the problem and excludes training cost [VERIFICATION NEEDED: cite benchmarks; earlier "millions of times faster" claim removed].
3. Closing the Loop: A stated aspiration is the "self-driving laboratory," in which AI agents propose hypotheses, control robotic hardware, evaluate results and update, with limited human intervention. This is a goal of some research programs, not an established capability.

Early intersections of AI and science were largely symbolic. The DENDRAL expert system, developed at Stanford from the 1960s, is generally described as inferring molecular structure from mass spectrometry data, and as depending on extensive manual knowledge engineering [VERIFICATION NEEDED: no primary reference cited].

The paradigm shifted with the deep learning revolution. Instead of encoding rules, scientists began feeding massive biological and physical datasets into neural networks. At the CASP14 assessment in 2020, DeepMind's AlphaFold 2 achieved a median backbone r.m.s.d.95 of 0.96 Å on assessed domains, versus 2.8 Å for the next-best method [figures as reported in the paper's abstract per the audit; VERIFICATION NEEDED: confirm against the full text] (Jumper et al., 2021). The authors describe the method as the first to regularly predict structures with atomic accuracy when no similar structure is known. The structure-prediction problem is often described as largely solved for single-chain proteins, though limitations remain, for example for conformational dynamics, multi-state proteins and low-confidence regions.

Following AlphaFold, the methodology rapidly expanded into material science (for example, GNoME, which Merchant et al. (2023) report predicted 2.2 million stable crystal structures, a result whose novelty and usefulness has been disputed; see section 5), weather forecasting (GraphCast; Lam et al., 2023), and generative protein design (RFdiffusion; Watson et al., 2023). [VERIFICATION NEEDED: the earlier mention of fluid dynamics had no source and is removed.]

#4.1 Equivariant Neural Networks

Physical and chemical systems must obey the laws of physics. If a molecule is rotated in 3D space, its physical properties do not change, but its Cartesian coordinates do. Some AI models in science use E(3)-equivariant neural networks, which are constructed to respect the symmetries of 3D space (rotations, translations, reflections). Proponents report improved data efficiency for some tasks [VERIFICATION NEEDED: cite equivariant-network papers such as NequIP; the effect depends on the task]. Not all successful models use exact equivariance.

#4.2 Neural Solvers and Surrogates

Simulating complex physics (weather, plasma fusion, fluid dynamics) requires numerical solvers that discretize time and space, requiring immense supercomputing clusters. AI models act as neural surrogates. Once trained on the outputs of the slow, exact simulator, the neural network learns to predict the final state directly in a single forward pass, in some reported cases accelerating simulations substantially at the cost of some accuracy; surrogates carry no general accuracy guarantee and can be unreliable out of distribution (section 7).

#4.3 Generative Design

Instead of screening millions of existing molecules to find a cancer drug, diffusion models are used to perform de novo generative design. Conditioned on a specific target (like a cancer cell receptor), the diffusion model can generate candidate structures, for example protein backbones in RFdiffusion (Watson et al., 2023). Generated candidates generally require downstream filtering and experimental testing, and success rates are task dependent; optimization for binding affinity and synthesizability is not guaranteed.

• Structural Biology: Protein structure prediction (AlphaFold), including biomolecular complexes (Abramson et al., 2024), and generative protein design.
• Materials Science: Crystal structure prediction (e.g., GNoME). Merchant et al. (2023) report 2.2 million structures predicted below the convex hull and that 736 of the stable structures had been independently experimentally realized; the paper is not cited here for superconductor discovery, and that earlier claim is removed. Cheetham and Seshadri (2024) argue that sampled entries lack strikingly novel compounds; DeepMind disputes the characterization. The result is Contested.
• Climate and Geoscience: GraphCast (Lam et al., 2023) predicts hundreds of weather variables for 10 days at 0.25 degree resolution in under a minute, and the authors report that it significantly outperforms the most accurate operational deterministic system (ECMWF HRES) on 90% of 1380 verification targets.
• Automated Laboratories: LLM agents with chemistry tools, such as ChemCrow (Bran et al., 2024). [VERIFICATION NEEDED: the scope of physically executed experiments in that paper was not checked; the earlier claim of general physical execution is not asserted.]

• AlphaFold 3 (2024): Abramson et al. (2024) report improved accuracy in predicting structures of biomolecular complexes, including proteins, nucleic acids and small-molecule ligands, on benchmarks. Claims about accelerating drug discovery are not supported by outcome-based evidence cited here and are not asserted.
• Tokamak plasma control: Degrave et al. (2022) report deep reinforcement learning controllers for magnetic control of plasma shapes. [VERIFICATION NEEDED: the experiments were reported on a research tokamak (TCV) in specific configurations, not a power reactor; confirm scope from the paper.]
• Mathematics: Trinh et al. (2024) report AlphaGeometry solving 25 of 30 olympiad-level geometry problems with known solutions, and Romera-Paredes et al. (2023) report FunSearch finding new constructions for problems such as the cap set problem. [VERIFICATION NEEDED: the claim that AI is "assisting top mathematicians" on unsolved theorems is unsourced beyond these results and is not asserted; the FunSearch scope was not checked beyond the title.]

#Limitations

• The OOD Reality Gap: AI models learn from existing data. If a generative model proposes a molecule with an entirely novel bonding structure far outside the training distribution (Out of Distribution, OOD), the model's prediction of its stability is highly unreliable.
• Hallucination in Science: LLM-based research assistants can confidently cite non-existent papers or hallucinate chemical synthesis routes that are physically impossible or highly explosive.
• Data Scarcity: Unlike the internet text used to train LLMs, high-quality empirical scientific data (e.g., quantum chemistry calculations, clinical trial results) is extremely expensive to generate, highly proprietary, and scarce.

#Unresolved Scientific Questions

1. Interpretability vs. Accuracy: Neural surrogates can predict weather accurately, but they often do not provide a human-readable explanation, although interpretability and symbolic-regression methods can extract partial explanations [VERIFICATION NEEDED: cite]. Can AI-found results yield underlying physical understanding, or does some science become black-box engineering?
2. Automated Verification: Can an autonomous AI agent definitively prove the viability of a novel drug target in a wet-lab environment without human oversight?

Some commentators regard AI4Science as among the most beneficial applications of AI; this is a value judgement, and generative biological design also raises biosecurity concerns (see section 10). Generative design is an active area (Watson et al., 2023). Claims that AI-designed drugs have entered human clinical trials, and about pharmaceutical partnerships, are unsourced here [VERIFICATION NEEDED: cite trial registrations with compound, phase and status, and define "AI-designed"]. A commonly stated bottleneck is physical synthesis and testing in the laboratory.

The earlier near-, medium- and long-term bullets (open-source "democratization" of biomolecular design, "millions of experiments per week", AGI-derived grand unified theories) were unsourced, specific, and in one case in tension with the biosecurity concern in section 10; they are removed. One forecast is registered.

• Foundational Concepts:
  • TECH-DIFF-001 Diffusion Models: The architecture driving generative molecular design.
  • TECH-AGENT-001 Autonomous AI Agents: The planners driving self-driving laboratories.
• Advanced Implications & Future Trajectories:
  • AGI-PATH-001 Scientific Pathways to AGI: Discusses pathways to AGI; AlphaGeometry is mentioned there as a narrow neuro-symbolic example.
  • SAFE-XRISK-001 AI Existential Risk & Catastrophic Scenarios: The bio-security risks of democratizing generative pathogen design.